PRNewsWire · 17 Sept 2026positive
Pulsenmore has secured MHRA registration, allowing its Pulsenmore FC home ultrasound platform to be marketed across the United Kingdom and Northern Ireland. This extends the company's fertility platform into the UK market, where more than 100,000 IVF and fertility treatment cycles were performed in 2024.
Why it matters — A UK market entry would give Pulsenmore access to a large fertility-treatment market for its home ultrasound platform, broadening its commercial reach beyond existing regions.
PRNewsWire · 8 Sept 2026positive
Pulsenmore Ltd. announced that its home ultrasound system for follicular monitoring (the Pulsenmore FC system), designed for women undergoing IVF and fertility preservation treatments, has completed CE European registration. This marks the company's second product authorized in Europe and its first expansion beyond prenatal care into the broader women's health market.
Why it matters — For Pulsenmore watchers, this registration signals a strategic expansion into fertility care and the broader women's health market, broadening the company's product portfolio and European footprint beyond its prenatal care offering.
PRNewsWire · 31 Aug 2026neutral
Pulsenmore Ltd. announced its financial results and business highlights for the six-month period ended June 30, 2026. The company presented key operational, commercial, regulatory, and technological achievements along with financial updates, and management hosted a webcast to discuss the results and provide a business update.
Why it matters — This announcement provides PLSM watchers with the company's latest financial performance and operational progress across its remote maternal-fetal healthcare and home ultrasound business.
PRNewsWire · 24 Aug 2026neutral
Pulsenmore Ltd. announced it will release its financial results and business highlights for the six months ended June 30, 2026 on August 31, 2026 at 8:30 am ET, and will hold a conference call to discuss them. The company, which focuses on remote maternal-fetal healthcare and home ultrasound solutions, issued the announcement from Omer, Israel.
Why it matters — Investors tracking Pulsenmore will be able to review the company's first-half 2026 financial and operational performance when the results and accompanying conference call take place on August 31.
PRNewsWire · 19 Aug 2026positive
Pulsenmore announced the expansion of its home ultrasound activity in Israel, with its technology being integrated at the Lis Maternity and Women's Hospital at Ichilov, joining other medical centers that already use it in pregnancy monitoring pathways.
Why it matters — This expands adoption of Pulsenmore's home ultrasound technology at another major Israeli medical center, broadening its footprint in pregnancy monitoring.
